Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients.

HIV medicine - 1 Oct 2009

Cesari M, Caramma I, Antinori S, Adorni F, Galli M, Milazzo L

Abstract excerpt

OBJECTIVES: High serum total cholesterol and low-density lipoprotein (LDL) levels have been demonstrated to increase the probability of a sustained viral response (SVR) in chronic hepatitis C. Conversely, insulin resistance reduces SVR rates. We investigated the influence of baseline glucose and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Lymphocyte Count
Share to Hypercholesterolemia
Share to Hyperglycemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Lipodystrophy

Share to Lipoproteins, LDL

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 19785667
DOI: 10.1111/j.1468-1293.2009.00729.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19785667-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients.PMID 19785667Read ↗

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.Semantic proximity Read ↗

Rates and predictors of response to anti-viral treatment for hepatitis C virus in HIV/HCV co-infection in a nationwide study of 619 patients.Semantic proximity Read ↗

Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection.Semantic proximity Read ↗

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Semantic proximity Read ↗

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Semantic proximity Read ↗

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.Semantic proximity Read ↗

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.Semantic proximity Read ↗

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.Semantic proximity Read ↗

Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.Semantic proximity Read ↗

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.Semantic proximity Read ↗

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.Semantic proximity Read ↗

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.